UBS Reiterates Neutral Rating on Solventum (SOLV) On Acera Deal & Buy Back Announcement
Tweet Send to a Friend
UBS analyst Kevin Caliendo reiterated a Neutral rating and $79.00 price target on Solventum (NYSE: SOLV).The analyst commented, "This afternoon ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
